Author

Tae Kon Kim

Observed name: T. Kim

Institutions: VA Tennessee Valley Healthcare System, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

Observed institutions: Vanderbilt University, VA Tennessee Valley Healthcare System, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

ORCID: 0000-0002-5182-3870

Observed ORCID: 0000-0002-5182-3870

OpenAlex ID: A5018699666

Is Pseudo-progression post-CAR T therapy real?

2026 · Alicia Shin, Kian Rahbari, et al. · Clinical Hematology International

Abstract 6556: The role of VISTA in the lung tumor microenvironment of metastatic melanoma

2026 · Carly M. Fielder, Qianni Hu, et al. · Cancer Research

Altered Glucagon Secretion in Individuals Who Develop Diabetes after Allogenic Stem Cell Transplantation

2026 · Tae Kon Kim, Dungeng Peng, et al. · Transplantation and Cellular Therapy

ERK1/2 Inhibition Suppresses Allo-Reactive T cells, Leading to GVHD Inhibition

2026 · Anjali Raman, Ko-Eun Christina Lee, et al. · Transplantation and Cellular Therapy

799 Cutaneous leukocyte-endothelial interactions predict outcomes after hematopoietic cell transplantation

2022 · I. Saknite, J.R. Patrinely, et al. · Journal of Investigative Dermatology

Works count: 5

Citation count:

H-index:

I10-index: